Atatürk Üniversitesi Atatürk Üniversitesi
Ara
Yayınlara dön
Makale Tam Makale Uluslararası 2021

The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib

Ali Yılmaz, Melih Şimşek, Zekeriya Hannarici, Mehmet E. Buyukbayram, Mehmet Bilici, Salim B. Tekin

FUTURE ONCOLOGY Cilt 17 · Sayı 33 · ss. 4545–4559 · 01.10.2021
DOI ile aç

Özet

Aim: To show the prognostic significance of the glucose-to-lymphocyte ratio (GLR) in hepatocellular carcinoma (HCC). Patients & methods: A total of 150 patients with advanced HCC who were treated with sorafenib in our center between January 2011 and December 2019 were included in the study retrospectively. Neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio, prognostic nutritional index and GLR were analyzed to assess their prognostic value using Kaplan-Meier and Cox regression analysis before and after propensity score matching (PSM). Results: In univariate analysis before and after PSM, albumin-bilirubin grade, neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, lymphocyte-to-monocyte ratio, prognostic nutritional index, AFP level and GLR were found to be significantly associated with both progression-free and overall survival. In multivariate analysis before and after PSM, GLR, albumin-bilirubin grade and AFP were determined to be independent prognostic factors for progression-free and overall survival. Conclusion: The GLR prior to sorafenib treatment is a new prognostic biomarker that may predict survival in advanced HCC.

Anahtar kelimeler

SURVIVAL lymphocyte GLUCOSE Hepatocellular carcinoma prognosis sorafenib

Atıf için künye

Yılmaz, A., Şimşek, M., Hannarici, Z., Buyukbayram, M. E., Bilici, M., & Tekin, S. B. (2021). The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib. FUTURE ONCOLOGY, 17(33), 4545–4559. https://doi.org/10.2217/fon-2021-0457

BibTeX
@article{yilmaz2021-118934,
  author = {Yılmaz, Ali and Şimşek, Melih and Hannarici, Zekeriya and Buyukbayram, Mehmet E. and Bilici, Mehmet and Tekin, Salim B.},
  title = {The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib},
  journal = {FUTURE ONCOLOGY},
  year = {2021},
  volume = {17},
  number = {33},
  pages = {4545--4559},
  issn = {1479-6694},
  doi = {10.2217/fon-2021-0457},
  url = {https://akademik.atauni.edu.tr/yayinlar/118934-the-importance-of-the-glucose-to-lymphocyte-ratio-in-patients-with}
}